Chapman V, Dickenson A H
Department of Pharmacology, University College London, UK.
Eur J Pharmacol. 1992 Sep 4;219(3):427-33. doi: 10.1016/0014-2999(92)90484-l.
The effect of peripheral and intrathecal administration of the bradykinin B2 receptor antagonist HOE140 and the non-steroidal anti-inflammatory drug indomethacin were studied on the response of dorsal horn nociceptive neurones to formalin in the anaesthetized rat. Peripheral pretreatment with HOE140 reduced both phases of the formalin response whereas subcutaneous administration of indomethacin (5 mg/kg) reduced only the second phase. Pre-treatment with intrathecal HOE140 resulted in a dose-dependent reduction of the second phase whereas a high dose (500 micrograms) intrathecal indomethacin reduced both phases of the response. Bradykinin plays a role in peripheral nociception during the first and second phase of the response whereas the prostaglandins are only involved during the second phase. The converse is true centrally, the prostaglandins appear to be involved in both phases of the formalin response whereas bradykinin only plays a central role during the second phase of the response.
研究了缓激肽B2受体拮抗剂HOE140外周和鞘内给药以及非甾体抗炎药吲哚美辛对麻醉大鼠背角伤害性神经元对福尔马林反应的影响。HOE140外周预处理可降低福尔马林反应的两个阶段,而皮下注射吲哚美辛(5mg/kg)仅降低第二阶段。鞘内注射HOE140预处理导致第二阶段剂量依赖性降低,而高剂量(500微克)鞘内注射吲哚美辛可降低反应的两个阶段。缓激肽在反应的第一阶段和第二阶段的外周伤害感受中起作用,而前列腺素仅在第二阶段起作用。在中枢情况则相反,前列腺素似乎参与福尔马林反应的两个阶段,而缓激肽仅在反应的第二阶段起中枢作用。